Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic

Sashikanth Banappagari, Miriam Corti, Seth Pincus, Seetharama Satyanarayanajois

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Protein-protein interactions (PPI) play a crucial role in many biological processes and modulation of PPI using small molecules to target hot spots has therapeutic value. As a model system we will use PPI of human epidermal growth factor receptors (EGFRs). Among the four EGFRs, EGFR-HER2 and HER2-HER3 are well known in cancer. We have designed a small molecule that is targeted to modulate HER2-mediated signaling. Our approach is novel because the small molecule designed disrupts dimerization not only of EGFR-HER2, but also of HER2-HER3. In the present study we have shown, using surface plasmon resonance analysis, that a peptidomimetic, compound 5, binds specifically to HER2 protein extracellular domain and disrupts the dimerization of EGFRs. To evaluate the effect of compound 5 on HER2 signaling in vitro, Western blot and PathHunter assays were used. Results indicated that compound 5 inhibits the phosphorylation of HER2 kinase domain and inhibits the heterodimerization in a dose-dependent manner. Molecular modeling methods were used to model the PPI of HER2-HER3 heterodimer.

Original languageEnglish (US)
Pages (from-to)594-606
Number of pages13
JournalJournal of Biomolecular Structure and Dynamics
Volume30
Issue number5
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Peptidomimetics
Proteins
Dimerization
Biological Phenomena
Surface Plasmon Resonance
ErbB Receptors
Phosphotransferases
Western Blotting
Phosphorylation

Keywords

  • EGFR
  • HER2
  • Homology modeling
  • Pathhunter assay
  • Peptidomimetic
  • Protein-protein interactions
  • Surface plasmon resonance

ASJC Scopus subject areas

  • Molecular Biology
  • Structural Biology

Cite this

Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic. / Banappagari, Sashikanth; Corti, Miriam; Pincus, Seth; Satyanarayanajois, Seetharama.

In: Journal of Biomolecular Structure and Dynamics, Vol. 30, No. 5, 2012, p. 594-606.

Research output: Contribution to journalArticle

Banappagari, Sashikanth ; Corti, Miriam ; Pincus, Seth ; Satyanarayanajois, Seetharama. / Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic. In: Journal of Biomolecular Structure and Dynamics. 2012 ; Vol. 30, No. 5. pp. 594-606.
@article{b1dbe83e111149e9a6ef3c331b30a2b8,
title = "Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic",
abstract = "Protein-protein interactions (PPI) play a crucial role in many biological processes and modulation of PPI using small molecules to target hot spots has therapeutic value. As a model system we will use PPI of human epidermal growth factor receptors (EGFRs). Among the four EGFRs, EGFR-HER2 and HER2-HER3 are well known in cancer. We have designed a small molecule that is targeted to modulate HER2-mediated signaling. Our approach is novel because the small molecule designed disrupts dimerization not only of EGFR-HER2, but also of HER2-HER3. In the present study we have shown, using surface plasmon resonance analysis, that a peptidomimetic, compound 5, binds specifically to HER2 protein extracellular domain and disrupts the dimerization of EGFRs. To evaluate the effect of compound 5 on HER2 signaling in vitro, Western blot and PathHunter assays were used. Results indicated that compound 5 inhibits the phosphorylation of HER2 kinase domain and inhibits the heterodimerization in a dose-dependent manner. Molecular modeling methods were used to model the PPI of HER2-HER3 heterodimer.",
keywords = "EGFR, HER2, Homology modeling, Pathhunter assay, Peptidomimetic, Protein-protein interactions, Surface plasmon resonance",
author = "Sashikanth Banappagari and Miriam Corti and Seth Pincus and Seetharama Satyanarayanajois",
year = "2012",
doi = "10.1080/07391102.2012.687525",
language = "English (US)",
volume = "30",
pages = "594--606",
journal = "Journal of Biomolecular Structure and Dynamics",
issn = "0739-1102",
publisher = "Adenine Press",
number = "5",

}

TY - JOUR

T1 - Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic

AU - Banappagari, Sashikanth

AU - Corti, Miriam

AU - Pincus, Seth

AU - Satyanarayanajois, Seetharama

PY - 2012

Y1 - 2012

N2 - Protein-protein interactions (PPI) play a crucial role in many biological processes and modulation of PPI using small molecules to target hot spots has therapeutic value. As a model system we will use PPI of human epidermal growth factor receptors (EGFRs). Among the four EGFRs, EGFR-HER2 and HER2-HER3 are well known in cancer. We have designed a small molecule that is targeted to modulate HER2-mediated signaling. Our approach is novel because the small molecule designed disrupts dimerization not only of EGFR-HER2, but also of HER2-HER3. In the present study we have shown, using surface plasmon resonance analysis, that a peptidomimetic, compound 5, binds specifically to HER2 protein extracellular domain and disrupts the dimerization of EGFRs. To evaluate the effect of compound 5 on HER2 signaling in vitro, Western blot and PathHunter assays were used. Results indicated that compound 5 inhibits the phosphorylation of HER2 kinase domain and inhibits the heterodimerization in a dose-dependent manner. Molecular modeling methods were used to model the PPI of HER2-HER3 heterodimer.

AB - Protein-protein interactions (PPI) play a crucial role in many biological processes and modulation of PPI using small molecules to target hot spots has therapeutic value. As a model system we will use PPI of human epidermal growth factor receptors (EGFRs). Among the four EGFRs, EGFR-HER2 and HER2-HER3 are well known in cancer. We have designed a small molecule that is targeted to modulate HER2-mediated signaling. Our approach is novel because the small molecule designed disrupts dimerization not only of EGFR-HER2, but also of HER2-HER3. In the present study we have shown, using surface plasmon resonance analysis, that a peptidomimetic, compound 5, binds specifically to HER2 protein extracellular domain and disrupts the dimerization of EGFRs. To evaluate the effect of compound 5 on HER2 signaling in vitro, Western blot and PathHunter assays were used. Results indicated that compound 5 inhibits the phosphorylation of HER2 kinase domain and inhibits the heterodimerization in a dose-dependent manner. Molecular modeling methods were used to model the PPI of HER2-HER3 heterodimer.

KW - EGFR

KW - HER2

KW - Homology modeling

KW - Pathhunter assay

KW - Peptidomimetic

KW - Protein-protein interactions

KW - Surface plasmon resonance

UR - http://www.scopus.com/inward/record.url?scp=84865651620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865651620&partnerID=8YFLogxK

U2 - 10.1080/07391102.2012.687525

DO - 10.1080/07391102.2012.687525

M3 - Article

C2 - 22731912

AN - SCOPUS:84865651620

VL - 30

SP - 594

EP - 606

JO - Journal of Biomolecular Structure and Dynamics

JF - Journal of Biomolecular Structure and Dynamics

SN - 0739-1102

IS - 5

ER -